Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt repayments
Ratios

Avanos Medical (AVNS) Cost of Revenue (2016 - 2026)

Avanos Medical's Cost of Revenue history spans 13 years, with the latest figure at $94.9 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 16.3% to $94.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $347.3 million, a 13.31% increase, with the full-year FY2025 number at $347.3 million, up 13.31% from a year prior.
  • Cost of Revenue hit $94.9 million in Q4 2025 for Avanos Medical, up from $91.8 million in the prior quarter.
  • Over the last five years, Cost of Revenue for AVNS hit a ceiling of $100.0 million in Q2 2021 and a floor of $3.5 million in Q4 2021.
  • Historically, Cost of Revenue has averaged $77.3 million across 5 years, with a median of $78.0 million in 2023.
  • Biggest five-year swings in Cost of Revenue: crashed 96.45% in 2021 and later surged 2148.57% in 2022.
  • Tracing AVNS's Cost of Revenue over 5 years: stood at $3.5 million in 2021, then surged by 2148.57% to $78.7 million in 2022, then fell by 0.51% to $78.3 million in 2023, then increased by 4.21% to $81.6 million in 2024, then grew by 16.3% to $94.9 million in 2025.
  • Business Quant data shows Cost of Revenue for AVNS at $94.9 million in Q4 2025, $91.8 million in Q3 2025, and $82.9 million in Q2 2025.